Protara Therapeutics (TARA) Short Interest Ratio & Short Volume $2.35 +0.06 (+2.62%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Protara Therapeutics Short Interest DataCurrent Short Interest1,800,000 sharesPrevious Short Interest1,770,000 sharesChange Vs. Previous Month+1.69%Dollar Volume Sold Short$4.28 millionShort Interest Ratio6.3 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares20,590,000 sharesPercentage of Shares Shorted8.74%Today's Trading Volume98,679 sharesAverage Trading Volume123,337 sharesToday's Volume Vs. Average80% Short Selling Protara Therapeutics ? Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARA Short Interest Over TimeTARA Days to Cover Over TimeTARA Percentage of Float Shorted Over Time Ad True Market InsidersThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 Protara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20241,800,000 shares $4.28 million +1.7%N/A6.3 $2.38 6/30/20241,770,000 shares $3.68 million +2.9%N/A5.9 $2.08 6/15/20241,720,000 shares $4.42 million +8.9%N/A4.2 $2.57 5/31/20241,580,000 shares $4.44 million +16.2%N/A4 $2.81 5/15/20241,360,000 shares $5.05 million +32.0%N/A3.6 $3.71 4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98 Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84 3/31/202465,200 shares $261,452.00 +6.2%0.7%0.3 $4.01 3/15/202461,400 shares $225,952.00 -22.3%0.7%0.8 $3.68 2/29/202479,000 shares $360,240.00 +33.9%0.9%1.1 $4.56 2/15/202459,000 shares $208,270.00 -33.0%0.7%0.8 $3.53 1/31/202488,100 shares $224,655.00 +19.2%1.1%1.5 $2.55 1/15/202473,900 shares $170,709.00 +1.5%0.9%1.3 $2.31 12/31/202372,800 shares $136,507.28 +46.8%0.9%1.3 $1.88 12/15/202349,600 shares $88,288.00 -16.2%0.6%1.1 $1.78 11/30/202359,200 shares $85,840.00 +22.3%0.7%1.6 $1.45 11/15/202348,400 shares $58,080.00 +1.7%0.6%1.6 $1.20 10/31/202347,600 shares $59,271.52 -3.3%0.6%1.9 $1.25 10/15/202349,200 shares $81,180.00 -4.3%0.6%2.5 $1.65 9/30/202351,400 shares $85,838.00 +5.5%0.6%2.2 $1.67 9/15/202348,700 shares $90,095.00 -7.4%0.6%1.8 $1.85 8/31/202352,600 shares $114,668.00 +14.4%0.6%1.8 $2.18 8/15/202346,000 shares $109,020.00 -40.8%0.6%1.4 $2.37 7/31/202377,700 shares $201,243.00 -28.5%0.9%2.3 $2.59 7/15/2023108,600 shares $298,650.00 +10.0%1.3%2.9 $2.75 6/30/202398,700 shares $235,893.00 -9.0%1.2%2.7 $2.39 6/15/2023108,400 shares $308,940.00 +11.0%1.3%3.2 $2.85 5/31/202397,700 shares $272,583.00 +0.2%1.2%2.7 $2.79 5/15/202397,500 shares $328,575.00 -4.6%1.2%2.6 $3.37 4/30/2023102,200 shares $322,952.00 +34.1%1.2%3.2 $3.16 4/15/202376,200 shares $221,742.00 -0.4%0.9%2.4 $2.91 3/31/202376,500 shares $239,445.00 -0.4%0.9%3.2 $3.13 3/15/202376,800 shares $235,776.00 -0.9%0.9%3.2 $3.07 2/28/202377,500 shares $273,575.00 -5.8%0.9%4.2 $3.53 2/15/202382,300 shares $264,183.00 -2.4%0.9%4.5 $3.21 1/31/202384,300 shares $275,239.50 -0.6%1.0%3.5 $3.27 1/15/202384,800 shares $284,928.00 -1.5%1.0%3.2 $3.36 12/30/202286,100 shares $230,748.00 +8.4%1.0%3 $2.68 12/15/202279,400 shares $243,758.00 -30.8%0.9%2.5 $3.07 11/30/2022114,700 shares $404,891.00 +22.7%1.3%3 $3.53We just added a $300 account credit to your MarketBeat subscription (Ad)MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.Start Your Risk-Free Trial Here 11/15/202293,500 shares $276,760.00 +7.5%1.0%2.2 $2.96 10/31/202287,000 shares $267,090.00 +2.7%1.0%2 $3.07 10/15/202284,700 shares $281,204.00 -16.6%1.0%2.1 $3.32 9/30/2022101,600 shares $300,736.00 -9.5%1.2%2.8 $2.96 9/15/2022112,200 shares $433,092.00 +14.5%1.3%2.6 $3.86 8/31/202298,000 shares $338,100.00 +9.0%1.2%2.3 $3.45 8/15/202289,900 shares $311,953.00 -1.0%1.1%2.4 $3.47 7/31/202290,800 shares $271,492.00 -32.7%1.1%2.4 $2.99 7/15/2022135,000 shares $422,550.00 +32.1%1.6%3.6 $3.13 6/30/2022102,200 shares $299,446.00 -32.4%1.2%2.7 $2.93 6/15/2022151,200 shares $471,744.00 -5.0%1.8%4.7 $3.12 5/31/2022159,200 shares $531,728.00 +5.5%1.9%5.6 $3.34 5/15/2022150,900 shares $436,101.00 +1.6%1.8%4.9 $2.89 4/30/2022148,500 shares $543,510.00 -6.8%1.8%4.9 $3.66 4/15/2022159,400 shares $730,052.00 -15.5%1.9%4.8 $4.58 3/31/2022188,700 shares $964,257.00 -8.0%2.2%5 $5.11 3/15/2022205,100 shares $916,797.00 -30.4%2.4%3.9 $4.47 2/28/2022294,500 shares $1.36 million +17.9%3.5%5.1 $4.63 2/15/2022249,900 shares $1.31 million -10.3%3.0%4 $5.25 1/31/2022278,500 shares $1.45 million -8.3%3.2%3.7 $5.21 1/15/2022303,700 shares $1.93 million -19.8%3.4%3.5 $6.37 12/31/2021378,600 shares $2.56 million -3.1%4.2%1.2 $6.75 12/15/2021390,700 shares $2.56 million +32.3%4.3%1.3 $6.56 11/30/2021295,300 shares $2.03 million -7.4%3.2%0.9 $6.89 11/15/2021318,800 shares $2.28 million -11.4%3.5%1 $7.15 10/29/2021359,600 shares $2.49 million -20.7%4.0%1.1 $6.92 10/15/2021453,400 shares $3.10 million +249.9%5.0%1.4 $6.84 9/30/2021129,600 shares $896,832.00 -36.0%1.4%1.2 $6.92 9/15/2021202,600 shares $1.44 million -1.9%2.2%1.8 $7.10 8/31/2021206,600 shares $1.73 million +9.3%2.3%2.3 $8.39 8/13/2021189,000 shares $1.33 million -2.3%2.1%1.9 $7.03 7/30/2021193,400 shares $1.53 million +1.9%2.1%2.1 $7.93 7/15/2021189,800 shares $1.61 million +27.9%2.0%1.4 $8.48 6/30/2021148,400 shares $1.45 million -52.2%1.6%1 $9.74 6/15/2021310,700 shares $3.26 million +2.4%3.3%2.3 $10.49 5/28/2021303,300 shares $2.88 million -1.1%3.2%2.2 $9.48 5/14/2021306,800 shares $2.66 million -10.7%3.2%2.4 $8.68 4/30/2021343,400 shares $3.91 million +20.2%3.5%2.6 $11.39 4/15/2021285,700 shares $4.85 million -1.1%2.9%2.4 $16.99 3/31/2021288,900 shares $4.07 million +38.8%3.0%3.1 $14.10 3/15/2021208,200 shares $3.71 million +34.2%2.1%2.1 $17.82 2/26/2021155,100 shares $2.73 million +14.1%1.6%1.6 $17.61 2/12/2021135,900 shares $2.77 million +0.3%1.4%1.5 $20.37 1/29/2021135,500 shares $2.56 million +25.1%1.4%1.4 $18.88 1/15/2021108,300 shares $2.18 million -2.0%1.1%1.2 $20.14 12/31/2020110,500 shares $2.67 million +83.3%1.2%1.2 $24.15 12/15/202060,300 shares $1.34 million +45.0%0.6%0.5 $22.17 11/30/202041,600 shares $965,120.00 -19.2%0.4%0.4 $23.20 11/15/202051,500 shares $1.11 million +12.5%0.5%0.5 $21.48 10/30/202045,800 shares $854,628.00 +23.8%0.5%0.5 $18.66Heard about the 72-Hour Profit Surge? Read this… (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. 10/15/202037,000 shares $696,710.00 +6.6%0.4%0.5 $18.83 9/30/202034,700 shares $584,001.00 -28.8%0.4%0.6 $16.83 9/15/202048,700 shares $946,728.00 -6.4%1.1%1.4 $19.44 8/31/202052,000 shares $1.11 million -7.6%1.2%1.8 $21.40 8/14/202056,300 shares $1.35 million -8.8%1.3%1.9 $24.00 7/31/202061,700 shares $1.54 million +23.7%1.5%2.1 $24.94 7/15/202049,900 shares $1.33 million +7.8%1.2%2 $26.67 6/30/202046,300 shares $1.43 million +223.8%1.1%1.9 $30.80 6/15/202014,300 shares $434,148.00 +210.9%0.4%0.8 $30.36 5/29/20204,600 shares $223,054.00 +12.2%0.1%0.3 $48.49 5/15/20204,100 shares $98,605.00 +86.4%0.1%0.4 $24.05 4/30/20202,200 shares $53,900.00 -42.1%0.1%0.2 $24.50 4/15/20203,800 shares $91,200.00 -33.3%0.1%0.3 $24.00 3/31/20205,700 shares $136,629.00 +42.5%0.1%0.4 $23.97 3/13/20204,000 shares $89,240.00 +400.0%0.8%0.4 $22.31 2/28/2020800 shares $16,816.00 -89.2%0.2%0.1 $21.02 2/14/20207,400 shares $179,080.00 +1.4%1.4%0.5 $24.20 1/31/20207,300 shares $202,210.00 +10.6%3.3%0.6 $27.70 1/15/20206,600 shares $246,180.00 -88.7%N/A0.8 $37.30 12/31/201958,500 shares $1.96 million No ChangeN/A7.8 $33.50 TARA Short Interest - Frequently Asked Questions What is Protara Therapeutics' current short interest? Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 1,800,000 shares of TARA short. Learn More on Protara Therapeutics' current short interest. What is a good short interest ratio for Protara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 6.0. Learn More on Protara Therapeutics's short interest ratio. Is Protara Therapeutics' short interest increasing or decreasing? Protara Therapeutics saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,800,000 shares, an increase of 1.7% from the previous total of 1,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Protara Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Protara Therapeutics: Brainstorm Cell Therapeutics Inc. (1.54%), Champions Oncology, Inc. (0.80%), Candel Therapeutics, Inc. (7.55%), Fennec Pharmaceuticals Inc (8.62%), Innate Pharma S.A. (0.09%), Acumen Pharmaceuticals, Inc. (3.74%), Adverum Biotechnologies, Inc. (9.37%), INmune Bio, Inc. (20.28%), Zura Bio Limited (5.41%), Kodiak Sciences Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Protara Therapeutics stock? Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protara Therapeutics? A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further. How often is Protara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BCLI Short Squeeze CSBR Short Squeeze CADL Short Squeeze FENC Short Squeeze IPHA Short Squeeze ABOS Short Squeeze ADVM Short Squeeze CGEN Short Squeeze INMB Short Squeeze ZURA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
